These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16621793)

  • 1. Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.
    Chalovich EM; Zhu JH; Caltagarone J; Bowser R; Chu CT
    J Biol Chem; 2006 Jun; 281(26):17870-81. PubMed ID: 16621793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling.
    Weng Z; Signore AP; Gao Y; Wang S; Zhang F; Hastings T; Yin XM; Chen J
    J Biol Chem; 2007 Nov; 282(47):34479-91. PubMed ID: 17895242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.
    Zhu JH; Kulich SM; Oury TD; Chu CT
    Am J Pathol; 2002 Dec; 161(6):2087-98. PubMed ID: 12466125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
    Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid interference between glucocorticoids and cAMP-activated signalling in hypothalamic neurones prevents binding of phosphorylated cAMP response element binding protein and glucocorticoid receptor at the CRE-Like and composite GRE sites of thyrotrophin-releasing hormone gene promoter.
    Díaz-Gallardo MY; Cote-Vélez A; Charli JL; Joseph-Bravo P
    J Neuroendocrinol; 2010 Apr; 22(4):282-93. PubMed ID: 20136691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family.
    Manna PR; Dyson MT; Eubank DW; Clark BJ; Lalli E; Sassone-Corsi P; Zeleznik AJ; Stocco DM
    Mol Endocrinol; 2002 Jan; 16(1):184-99. PubMed ID: 11773448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of niemann-pick c1 gene expression by the 3'5'-cyclic adenosine monophosphate pathway in steroidogenic cells.
    Gévry NY; Lalli E; Sassone-Corsi P; Murphy BD
    Mol Endocrinol; 2003 Apr; 17(4):704-15. PubMed ID: 12554781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.
    Sun X; Aimé P; Dai D; Ramalingam N; Crary JF; Burke RE; Greene LA; Levy OA
    Exp Neurol; 2018 May; 303():95-107. PubMed ID: 29432724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1).
    Stachowiak EK; Fang X; Myers J; Dunham S; Stachowiak MK
    J Neurochem; 2003 Mar; 84(6):1296-312. PubMed ID: 12614330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
    Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
    J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK.
    Ugarte SD; Lin E; Klann E; Zigmond MJ; Perez RG
    J Neurosci Res; 2003 Jul; 73(1):105-12. PubMed ID: 12815714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.
    Izumi Y; Sawada H; Sakka N; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
    J Neurosci Res; 2005 Mar; 79(6):849-60. PubMed ID: 15712215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells.
    Lin E; Cavanaugh JE; Leak RK; Perez RG; Zigmond MJ
    J Neurosci Res; 2008 Jan; 86(1):108-17. PubMed ID: 17847117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells.
    Hara H; Ohta M; Ohta K; Kuno S; Adachi T
    Brain Res Mol Brain Res; 2003 Nov; 119(2):125-31. PubMed ID: 14625079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperphosphorylation of CREB in human dopaminergic neurons: a kinetic study of cellular distribution of total CREB and phospho-CREB following oxidative stress.
    Ahmed BY; Husnain O; Stafford R; Howard M; Gujar AS; Moradiya V; Patel KK; Sihotra S
    Neuroreport; 2013 Sep; 24(13):757-62. PubMed ID: 23921595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal recruitment of transcription factors at the 3',5'-cyclic adenosine 5'-monophosphate-response element of the human GnRH-II promoter.
    Poon SL; An BS; So WK; Hammond GL; Leung PC
    Endocrinology; 2008 Oct; 149(10):5162-71. PubMed ID: 18599546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salt-inducible kinase-1 represses cAMP response element-binding protein activity both in the nucleus and in the cytoplasm.
    Katoh Y; Takemori H; Min L; Muraoka M; Doi J; Horike N; Okamoto M
    Eur J Biochem; 2004 Nov; 271(21):4307-19. PubMed ID: 15511237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.